NYSE: ALBAlbemarle Corp Stock
$64.95+1.20 (+1.88%)
Updated Jun 27, 2025
ALB Price
$64.95
Fair Value Price
N/A
Market Cap
$7.64B
52 Week Low
$49.43
52 Week High
$113.91
P/E
-5.84x
P/B
0.76x
P/S
1.66x
PEG
N/A
Dividend Yield
2.5%
Revenue
$5.09B
Earnings
-$1.14B
Gross Margin
3.5%
Operating Margin
-17.22%
Profit Margin
-25.7%
Debt to Equity
0.67
Operating Cash Flow
$1B
Beta
1.56
Next Earnings
N/A
Ex-Dividend
Jun 13, 2025
Next Dividend
Jul 1, 2025
ALB Overview
Albemarle Corporation manufactures specialty chemicals (lithium, bromine, and catalysts). Offerings based on those chemicals include butyllithium and lithium aluminum hydride, products used in fire safety solutions, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions. Its customers include companies in the energy storage, petroleum refining, and consumer electronics sectors, among others. The company was founded in 1887 and is headquartered in Charlotte, NC.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ALB's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important ALB news, forecast changes, insider trades & much more!
ALB News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ALB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ALB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ALB is good value based on its book value relative to its share price (0.76x), compared to the US Specialty Chemicals industry average (3.32x)
P/B vs Industry Valuation
ALB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more ALB due diligence checks available for Premium users.
Valuation
ALB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-5.84x
Industry
9.71x
Market
32.24x
ALB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.76x
Industry
3.32x
ALB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ALB's financial health
Profit margin
Revenue
$1.1B
Net Income
$41.3M
Profit Margin
0%
ALB's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ALB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$17.0B
Liabilities
$6.7B
Debt to equity
0.67
ALB's short-term assets ($4.11B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALB's long-term liabilities ($4.78B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$545.4M
Investing
-$179.3M
Financing
-$120.0M
ALB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ALB vs Specialty Chemical Stocks
Albemarle Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.